Consumer's knowledge, perceptions, and responsiveness to direct-to-consumer advertising of prescription medicines

New Zealand Medical Journal

Volumn 120, Issue 1249, 2007, Pages

  Hoek, Janet A ^a   Maubach, Ninya ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; AWARENESS; CONSUMER ATTITUDE; CONTROLLED STUDY; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; HEALTH CARE POLICY; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; NEW ZEALAND; PATIENT EDUCATION; POSTAL MAIL; PRESCRIPTION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RANDOM SAMPLE; SELF CONCEPT; SELF EVALUATION;

EID: 33847626395     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Rosenthal M, Berndt J, Donohue M, et al. Promotion of prescription drugs to consumers. New Engl J Med. 2002;345:498-505.
2. Toop L, Richards D, Dowell T, et al. Direct to consumer advertising of prescription drugs in New Zealand: For health or for profit? Report to the Minister of Health supporting the case for a ban on DTCA; 2003. URL: http://www.chmeds.ac.nz/report.pdf
3. Lexchin J, Mintzes B. Direct-to-consumer advertising of prescription drugs: The evidence says no. J Public Policy Marketing. 2002;21:194-202.
4. Moynihan R, Heath I, Henry D. Selling sickness: The pharmaceutical industry and disease mongering. BMJ. 2002;324:886-91.
5. Davis J. Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs. J Health Commun. 2001;5:349-69.
6. Cockburn J, Pit S. Prescribing behaviour in clinical practice: Patients' expectations and doctors' perceptions of patients' expectations. BMJ. 1997;315:520-3.
7. Wolfe SM. Direct-to-consumer advertising: Education or emotion promotion? New Engl J Med. 2002;346:524-6.
8. Lipsky MS, Taylor CA. The opinions and experiences of family physicians regarding direct-to-consumer advertising. J Fam Pract. 1997;45:495-9.
9. Coney S. Direct to consumer advertising of prescription pharmaceuticals: A consumer perspective from New Zealand. J Public Policy Marketing. 2002;21:213-23.
10. Mansfield PR. Report on DTC pharmaceutical promotion for PHARMAC; 1999. URL http://www.healthyskepticism.org/other/dtca/ Report%20on%20DTCA%20for%20PHARMAC.doc
11. Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: Trends, impact and implications. Health Aff. 2000;19:110-28.
12. Bell RA, Kravitz RL, Wilkes MS. Direct-to-consumer prescription drug advertising and the public. J Gen Intern Med. 1999;14:651-7.
13. Hollon M. Direct-to-consumer marketing of prescription drugs. JAMA. 1999;281:382-4.
14. Pharmac. Pharmac submission for Ministry of Health review of direct to consumer advertising. Wellington: Pharmac; 2000.
15. Vaithianathan R. Better the devil you know to the doctor you don't: Is advertising drugs to doctors more harmful than DTC?; 2004, 28 September. URL: Http://homes.eco.auckland.ac.nz/rvai001/DTCA6.doc
16. Pinto M, Pinto J, Barber J. The impact of pharmaceutical direct advertising: Opportunities and obstructions. Health Marketing Quart. 1998;15:89-101.
17. Kelly P. Advancing public health through effective consumer health communication. Presentation to Food and Drug Administration DTC public hearing; 2005, 1 November. URL: Http://www.fda.gov/cder/ddmac/dtc2005/ Kelly.ppt
18. Holmer A. Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. JAMA. 1999;281:380-2.
19. Calfee J. Public policy issues in direct-to-consumer advertising of prescription drugs. J Public Policy Marketing. 2002;21:174-93.
20. Calfee J. What do we know about direct-to-consumer advertising of prescription drugs? Health Aff. 2003;Web Exclusive(February):W3:116-W3:9.
21. Bradford WD, Kleit AN. Evaluating the welfare effects of drug advertising. Regulation. 2006;29:58-62.
22. Saunders B. Direct to consumer advertising: Where does the public interest lie? N Z Med J. 2003;116(1180). URL: Http://www.nzma.org.nz/ journal/116-1180/557/
23. Researched Medicines Industry Association of New Zealand. DTC advertising can enhance public health: The case for direct-to-consumer prescription medicine advertising. 2000, June. URL: http://www.rmianz.co.nz/pdfs/fulldtc.pdf
24. Center for Drug Evaluation and Research. Attitudes and behaviors associated with direct-to-consumer (DTC) promotion of prescription drugs: Main survey results; 2006, 13 JHnuary. URL: http://www.fda.gov/ cder/ddmac/dtcindex.htm
25. Food and Drug Administration. Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs: Summary of FDA survey research results. 2004, 19 November. URL: http://www.fda.gov/cder/ddmac/Final%20Report/FRfinal111904.pdf
26. Hoek JA, Gendall P. Direct to consumer advertising of prescription medicines: A consumer survey. Palmerston North: Department of Marketing, Massey University; 2003.
27. Hoek JA, Gendall P, Calfee J. Direct-to-consumer-advertising of prescription medicine in the United States and New Zealand: An analysis of regulatory approaches and consumer responses. Int J Advertising. 2004;23:197-227.
28. Kopp S, Bang HK. Benefit and risk information in prescription drug advertising: A review of empirical studies and marketing implications. Health Mgmt Quart. 2000;17:399-56.
29. Anthony JJ, Hoek JA, Holdershaw J. Communication of risks and side effects in prescription medicine advertising. In: Geursen G, Kennedy R, Tolo M, editors. Australia New Zealand Marketing Academy Conference. Adelaide: ANZMAC, 2003:83-9.
30. Slaughter E. 5th annual survey: Consumer reaction to DTC advertising of prescription medicines: Honoring requests for prescription medicines. Emmaus, Pa: Prevention Magazine, Rodale Publications; 2002.
31. Hoek JA, Gendall P. Wishful thinking or hardcore hostility? Viewers' responses to television advertising. Int J Advertising. 1994;13:461-72.
32. Conner M, Norman P. Health behavior. In: Johnston, DW, Johnston, M, editors. Comprehensive clinical psychology volume 8: Health psychology. Amsterdam: Elsevier; 1998, p1-37.
33. Bandura A. Self-efficacy: Toward a unifying theory of behavioral change. Psych Rev. 1977;84:191-215.
34. Lennings C. An evaluation of a generalised self-efficacy scale. Personality and Individual Differences. 1994;16(5):745-50.
35. Bandura A. Self-efficacy: The exercise of control. New York: WH Freeman; 1997.
36. Rothschild ML. Carrots, sticks and promises: A conceptual framework for the management of public health and social issue behaviors. J Marketing. 1999;63:24-37.
37. Berry TR, Howe BL. The effects of exercise advertising on self-efficacy and decisional balance. Am J Health Behav. 2005;29:117-26.
38. Maubach, NB, Hoek, JA. New Zealand general practitioners' views on direct-to-consumer advertising of prescription medicines: A qualitative analysis. NZMJ. 2005;118(1215). URL: Http://www.nzma.org.nz/journal/ 118-1215/461/content.pdf